Prelude Therapeutics Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Wilmington, DE
SEC filing record 1 source field available
Fiscal year end
31 December
Prelude Therapeutics Inc has filed 386 SEC EDGAR filings since 11 Jul 2016

SEC filing history

Showing 176-200 of 386 matching filings.

Per page
25
Current page
8
4

FORM 4 SUBMISSION

Filing date
24 May 2023
Reporting date
22 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-261019

424B5

Filing date
19 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-261019

FWP

Filing date
18 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-261019

424B5

Filing date
17 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-39527

ARS

Filing date
28 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39527

DEFA14A

Filing date
28 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39527

DEF 14A

Filing date
28 Apr 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-39527

PRE 14A

Filing date
18 Apr 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Apr 2023
Reporting date
04 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-261019

424B5

Filing date
15 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-270549

S-8

Filing date
15 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Mar 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
22 Feb 2023
Reporting date
20 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91717

SC 13G filing

Filing date
13 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91717

SC 13G/A filing

Filing date
10 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91717

SC 13G/A

Filing date
10 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Feb 2023
Reporting date
07 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .